Language selection

Search

Patent 2082933 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2082933
(54) English Title: METHOD AND MEANS TO PERFORM BIOCHEMICAL REACTIONS
(54) French Title: METHODE ET MOYENS MIS EN OEUVRE POUR OBTENIR DES REACTIONS BIOCHIMIQUES
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • B01L 03/00 (2006.01)
  • B01L 03/14 (2006.01)
  • C12M 01/24 (2006.01)
  • C12Q 01/00 (2006.01)
  • G01N 33/50 (2006.01)
(72) Inventors :
  • MALMQUIST, MATS (Sweden)
(73) Owners :
  • MATS MALMQUIST
(71) Applicants :
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 2002-09-17
(86) PCT Filing Date: 1991-05-15
(87) Open to Public Inspection: 1991-11-28
Examination requested: 1998-04-17
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/SE1991/000343
(87) International Publication Number: SE1991000343
(85) National Entry: 1992-11-13

(30) Application Priority Data:
Application No. Country/Territory Date
9001772-4 (Sweden) 1990-05-16

Abstracts

English Abstract


The present invention relates to a method to perform biochemical reactions and
a combination of a capillary (3) and a
reaction vessel (1) for use in said method. The reagent capillaries (3)
contain frozen reagents (6-13) separated from each other by
air or an inert fluid. At use, the reagent capillaries (3) are placed in a
reaction vessel (1) to be thawed and then the contents are
centrifugated to the bottom of the reaction vessel (1). The invention is
intended for use in all types of biochemical standard reac-
tions and diagnostic tests in which the reagents, cannot be mixed in advandce.
It is particularly suitable for CPR diagnostics but is
also especially beneficial when handling radiactive reagents, e.g. labeled
nucleotides, at sequencing reactions, etc.


Claims

Note: Claims are shown in the official language in which they were submitted.


8
CLAIMS
1. Method to perform biochemical reactions in which the
reagents cannot be mixed in advance, wherein a reagent capillary
(3) is used being filled with reagents separated from each other,
characterized in that the reagent capillary (3) is inserted in
a first bore (4a) in the lid (4) of a reaction vessel (1), in
that the reaction vessel (1) with inserted capillary (3) is
centrifugated to bring the contents of the reagent capillary (3)
in the bottom of the reaction vessel (1), and in that the sample
to be reacted is added to the reaction vessel (1).
2. Method according to claim 1, characterized in that a
capillary containing the sample is inserted in a second bore (4a)
in the lid (4) of the reaction vessel (1), and in that a second
centrifugation is performed.
3. Method according to claim 1 or 2, characterized in that the
reagent solutions (6-13) are frozen and in that they are thawed
before centrifugation.
4. Method according to claim 1, 2 or 3, characterized in that
a protective cover (15) is fitted on the upper end of the reagent
capillary (3) before the lower end thereof is inserted in the
bore (4a), the lower end being so far down inserted in the
reaction vessel (1) until a looking groove (5) on the capillary
engages with the edges of the bore (4a).
5. Method according to claim 4, characterized in that the
reagent capillary (3) is inserted through a permeable membrane
(4b) covering the bore (4a).
6. Combination of reagent capillary and reaction vessel,
characterized in a reagent capillary (3) comprising different
reagent solutions (6-13) in predetermined volumes separated from
each other by air or an inert fluid, and a reaction vessel (1)
comprising a lid (4) provided with one or more bore(s) (4a) , the

9
reagent capillary (3) being intended to be inserted into the bore
(4a) in the lid (4) of the reaction vessel (1) at use.
7. Combination according to claim 6, characterized in that the
reagent solutions (6-13) are frozen and in that they are thawed
before the reagent capillary (3) is inserted into the bare (4a).
8. Combination according to claims 6 or 7, characterized in
that the reagent capillary (3) is provided with a locking groove
(5) at its lower end and a protective cover (15) at its upper
end.
9. Combination according to claims 6, 7 or 8, characterized in
that the bore (4a) is covered by a permeable membrane (4b).
10. Combination according to one or more of the claims 6-9,
characterized in that the reagent solutions (6-13) comprise
nucleic acid(s) and/or enzyme(s) for a specific reaction.
11. Combination according to claim 10, characterized in that the
reagent solutions (6-13) comprise PCR buffer, dCTP, dGTP, dATP,
dTTp, two or more oligonucleotides, all of the reagents being
calculated for a specific PCR reaction, and termostable DNA
polymerase.
12. Combination according to one or more of the claims 5-11,
characterized in that the reaction vessel (1) is made of a
material that does not or only slightly absorb UV light.

Description

Note: Descriptions are shown in the official language in which they were submitted.


wo 9m~~mo 1 ;~~:;~~~~~ Pcris~9moo~~3
METHOD AND MEANS TO PERFORM BIOCHEMICAL REACTIONS
The present invention relates to a method to perform biochemical
reactions and a combination of a capillary and a reaction vessel
for use in said method.
The invention is applicable far all small volume biochemical
reactions in which the reagents cannot be mixed beforehand.
Particularly, the invention is intended for the PCR (Polymerise
Chain Reaction)-technique.
The recently developed PCR-technique has led to great advances
in a number of important diagnostic sectors, e.g. the diagnosis
of many different diseases, determinations of paternity, forensic
medicine, etc. When it is desired to detect RNA, a necessary
preliminary stage is the conversion of the RNA into DNA by means
of the enzyme reverse transcriptase. The diagnosis of AzDS is
routinely made by~the detection of antibodies to the HIV-virus
in the blood by means of an ELISA (Enzyme Linked ImmunoSorbent)-
test. A person may, however, be HIV-positive without antibodies
being present if he/she, for instance, is in the early stages of
the disease. In this case the ELISA test gives a negative result
and the person concerned then risks unwittingly transmitting the
infection to others. Therefore the need for a better, i.e. more
sensitive, HIV test is very great. The diagnosis of other
viruses, also, the culture of which previously took a long time,
has been improved with the PCR technique.
As regards the practical procedure, PCR diagnosis comprises three
stages:
l) preparation of.the reaction mixtures, i.e. preparation of the
samples to be tested;
2 ) the actual amplification, r . e. the chain reaction in which the
a DNA.molecules are replicated exponentially; and
3) the detection of positive samples by means of electrophoresis
ar hybridisation.
A disadvantage of the PCR method which the present inventor aims
to eliminate is that stage 1) is time-consuming and demanding

Vd'~ 91/18110 PC'T/SE91/00'~43
e~'v. ~~ i~~3
2
work, primarily because the reagents cannot be mixed in advance,
and thus give rise to many sources of error. It is very important
that stage 1) should be carried out with great care and precision
because the amplification in stage 2) and the detection result
in stage 3) depend absolutely on the reliability of stage 1).
During the various stages of preparing the reagents for a
laiochemical reaction, such as PCR mentioned above, there is a
risk of cross-contamination between the different reaction
vessels or test tubes.
While preparing for a PCR reaction there is also a risk of so-
called '°carry-over contamination" from the person who handles the
sample. This applies especially to routine analysis to detect a
specific DNA if the same person carries out all the stages before
PCR reaction and also handles the PGR product. On skin, hair and
laboratory clothing there may be remnants of PCR products from
amplifications carried out previously which engender '°false'°
positive resluts. The risk of false positive results increases
the more sensitive the test. The test for HIV is very sensitive
and it need scarcely be said that a false positive result causes
needless distress to the individual notified of it.
The object of the invention was to deminish the contamination
risk .as well as the time required to grepare small reagent
volumes for a specific biochemical reaction in which the reagents
canf~ot be mixed in advance and the preparation is time-consuming.
This object is achieved by a method using a combination of a
capillary and a reaction vessel, according to claims 1 and 6,
respectively.
In DD-Al-225 788 a capillary is described, which contains several
reagents separated by intermediate hydrophobic liquid, e.g.
paraffines, oils, alkanes. In this capillary, reagent storage as
well as sample reaction takes place. The sample is added to the
capillary and then the capillary is melted at one end. The mixing

CA 02082933 2001-08-30
69520-30
3
of the sample with the :reagents is done in that a steel pin
is put into the capillary and a magnet is moved in an upward
and downward direction along the outside of the capillary.
After a suitable incubation period the capillary is
centrifugated to obtain the reaction solution and the
hydrophobic liquid in two separate phases. To be able to
analyze the reaction so:.Lution the capillary has to be cut at
the sealed end and also at the boundary between hydrophobic
liquid-reaction solution and thereafter the reaction
1C solution is transferred to a cuvette or the like, for
measurement of, for example, UV absorbance.
This known capillary solves the problem of
preparing reagents which cannot be prepared in advance.
However, because of the above mentioned handling stages,
15 there is no time savings nor reduction of contamination
compared to conventional pipetting techniques.
The invention will now be described in greater_
detail below with reference to the accompanying drawings in
which
20 Fig. 1 is a diagrammatic view if a reaction vessel
including a reagent capillary containing reagent;
Fig. 2 is a diagrammatic view of an alternative
embodiment of a reaction vessel including an alternative
embodiment of a reagent capillary;
25 Fig. 3 is a plan view of the embodiment shown in
Fig. 2;
Fig. 4 shows the reagent capillary depicted in
Fig. 1 on a larger scale; and

CA 02082933 2001-08-30
69520-30
3a
Fig. 5 shows the reagent capillary depicted in
Fig. 2 on a larger scale.
According to one aspect of the present invention,
there is provided a method to perform biochemical reactions
in which the reagents cannot be mixed in advance, wherein a
reagent capillary (3) i;~ used being filled with reagents
separated from each other, characterized in that the reagent
capillary (3) is inserted in a first bore (4a) in the lid
(4) of a reaction vessel (1), in that the reaction vessel
(1) with inserted capil=Lary (3) is centrifugated to bring
the contents of the reagent capillary (3) in the bottom of
the reaction vessel (1), and in that the sample to be
reacted is added to the .reaction vessel (1).
According to another aspect of the present
invention, there is provided a combination of reagent
capillary and reaction vessel, characterized in a reagent
capillary (3) comprising different reagent solutions (6--13)
in predetermined volumes separated from each other by air or
an inert fluid, and a reaction vessel (1) comprising a lid
(4) provided with one or more bores) (4a), the reagent
capillary (3) being intended to be inserted into the bore
(4a) in the lid (4) of the reaction vessel (1) at use.
Fig. 1 shows ~~ ready-prepared reaction vessel 1
according to the present. invention. Inside the reaction
vessel 1, for instance an

WO 91/18110
__ PL I'/S E~ 1 /00343
s~'~~ ~' ~ ~ i.~ a~
4
Eppendorf tube, is placed a reagent capillary 3. The reagent
Capillary 3 is provided with different reagents, which cnn be of
any Sul.table type for a desired reaction. In the bottom of the
reaction vessel 1 there may be water or buffer 2 for subsequent
dilution of the reagents.
Fig. 2 shows an alternative and preferred embodiment of a
reaction vessel 1 and a reagent capillary 3. The reaction vessel
1 is provided with a lid 4 having a bore 4a. The bore 4a is
covered by a permeable membrane 4b. The bore ~4a fitted with a
membrane is located centrally ir. the lid 4 in the shown em-
bodiment but this is not a critical feature. In fact it is
possible to provide the lid with several bores to be able to put
in more than one reagent capillary as desired. The bore 4a forms
a stop collar for the reagent capillary 3 in accordance with Fig.
5, which is described in greater detail below.
The reagent capillary 3 depicted in Fig. .~ is designed to be
inserted into the reagent vessel 1 shown in Fig. 1. The reagent
Capillary 3 is provided with different reagents 6-13 for a
specific biochemical reaction. The amount of each reagent is
calculated and intended only for this specific reaction. If a PCR
reaction is to be performed the reagent solutions 6-13 comprise
PCR buffer, dCTP, dGTP, dATP, dTTP, two or more oligonucleotides,
all of the reagents being calculated for a specific PCR reaction,
and termostable DNA polymerase. Between the reagents there is air
or do inert fluid. Naturally, the mutual order is optional.
A modified reagent capillary is depicted in Fig. 5. This reagent
capillary is designed to be inserted into a reaction vessel
according to Fig. 2. The reagent capillary differs from the
reagent capillary shown in Fig. 4 in that there is an annular
locking groove 5 on the lower part of the capillary intended to
be snapped into the bore ~la. Moreover, a protective cover 15 is
fitted over the upper end of the capillary. The reaction vessel
according to Fig. 2 and the reagent capillary according to Fig.
are stored separately until use. Upon use, the lower end of the

WO 91/18110 PCT/SE91/003d3
s ''~'~~~~~~
Capillary 3 1S pushed through the permeable membrane 4b in the
lid 4 of the reaction vessel 1, whereupon the locking groove 5
engages with the stop collar formed by the bore 4a. The protec-
tive Cover 15 protects the contents of the reagent capillary 3
from contamination during the process of insertion and pushing
into the reaction vessel 1. When the reagent solutions in the
reagent cagillary 3 have thawed, they are then centrifuged down
and mixed with one another and, where applicable, with the
diluent 2 at the bottom of the vessel 1. After centrifuging, the
lid 4 may be opened without having to remove the capillary 3 from
the lid. The advantage of this is that material can readily be
added to or extracted from the reaction vessel if desired.
After producing the reagent Capillaries, i.e. by aspirating the
different reagents with air or inert fluid in between, either
manually or automatically, they may be packed separately or
placed in a reaction vessel in kits for performing a specific
biochemical reaction. Of course, this packaging takes place under
sterile conditions.
An alternative method of producing the capillaries would be to
aspirate the reagents into capillaries with air or inert fluid
between the reagents, freeze the capillaries, cut the Capillaries
in tha air sections, and to place the desired capillary pieces
in one common outer capillary having an inner diameter eorrespon-
ding to the outer diameter of the capillary pieces. This would
allow combining of the reagents in any desired way.
The reagent capillaries with or without the reaction vessels axe
stored in the frozen state until use. For use the reagent
capillary is thawed and the contents thereof are centrifuged down
in the reaction vessel, being mixed with each other and with
diluent if any. If a PCR reaction is to be performed, all the
reagents, including heat stable DNA polymerise, are now in the
reaction vessel and the only further addition needed before the
amplification is of the sample, e.g. blood.

WO 91/1110
PC'T/SE91 /0343
6
Preferably the sample is added by using a dosing system described
in applicants pending swedish patent application SE 91 0726-0.
Briefly, the sample is drawn up into a capillary, of the same
type as reaction capillary 3, by the capillary effects. Thereaf-
ter the sample capillary is inserted in an unoccupied bore 4a in
the lid 4 of the reaction vessel 1 which thereafter is once again
centrifugated.
For fast detection of the results of the amplification reaction,
the present inventor suggest using material for the reaction
vessels that does not or only slightly absorb W light. If
ethidium bromide is added after the reaction it would then be
possible to detect whether or_not DNA has been amplified by
viewing the vessels under W light with the naked eye. Preferably
the ethidium brom~.de addition is made in the same manner as the
above described sample addition.
It should be appreciated the the shown reagent capillaries 3 have
been prepared for a specific sample volume and a specific
biochemical reaction. Other reactions require different volumes
and number of reagents.
According to the present invention numerous factors are obviated,
e.g. pipetting, changing pipette-tips, changing gloves, repeated
opening and closing of the reaction vessel, whereby the number
of sources of error is substantially reduced and the tests are
more. reliable, quicker and cheaper. The problem of false positive
results with PCR is thus appreciably reduced.
Thus the invention offers the biotechnical industry the chance
to supply a new type of "kits", i.e. complete sets containing
reagents for a specific reaction. Large numbers of such kits are
on the market today; they usually consist of Eppendorf tubes
containing different reagents suitable for about 100 standard
reactions . For each reaction a certain volume is mixed from each
tube. With the aid of reagent capillaries one kit can contain,
e.g. 500 capillaries, each ready to use for the reaction it is

!f0 91/1$110 PCT/SE91/00343
~~L;~~ i~..'~
7
designed for. The advantage of kits based in the reagent
capillaries desribed in the present application is that the user
does not have to pipette the reagent and is able, instead, to
select the appropriate reagent capillary for the relevant
reaction with fingers of tweezers. The simplification of the work
is obvious, above all in regard to the handling of radioactive
reagents, as there is no risk of contaminating pipettes, less
risk of radioactive waste and shorter periods of e.~posure for the
staff. In addition to the economic and operational advantages of
reaction capillaries in PCR technology, there is the saving in
time and the benefits of worker protection in many biotech-
nological sectors.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2018-01-01
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 2005-05-16
Letter Sent 2004-05-17
Grant by Issuance 2002-09-17
Inactive: Cover page published 2002-09-16
Inactive: Office letter 2002-07-10
Notice of Allowance is Issued 2002-07-10
Inactive: Approved for allowance (AFA) 2002-06-21
Letter Sent 2002-04-05
Reinstatement Request Received 2002-03-25
Pre-grant 2002-03-25
Withdraw from Allowance 2002-03-25
Final Fee Paid and Application Reinstated 2002-03-25
Inactive: Office letter 2001-12-03
Letter Sent 2001-09-10
Amendment After Allowance Requirements Determined Compliant 2001-09-10
Deemed Abandoned - Conditions for Grant Determined Not Compliant 2001-09-07
Amendment After Allowance (AAA) Received 2001-08-30
Inactive: Amendment after Allowance Fee Processed 2001-08-30
Inactive: Final fee received 2001-08-30
Letter Sent 2001-03-07
Notice of Allowance is Issued 2001-03-07
Notice of Allowance is Issued 2001-03-07
Inactive: Approved for allowance (AFA) 2001-02-21
Letter Sent 2000-06-08
Reinstatement Requirements Deemed Compliant for All Abandonment Reasons 2000-06-01
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2000-05-15
Amendment Received - Voluntary Amendment 1999-01-28
Inactive: Status info is complete as of Log entry date 1998-05-21
Letter Sent 1998-05-21
Inactive: Application prosecuted on TS as of Log entry date 1998-05-21
All Requirements for Examination Determined Compliant 1998-04-17
Request for Examination Requirements Determined Compliant 1998-04-17
Application Published (Open to Public Inspection) 1991-11-28

Abandonment History

Abandonment Date Reason Reinstatement Date
2002-03-25
2001-09-07
2000-05-15

Maintenance Fee

The last payment was received on 2002-05-07

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Request for examination - standard 1998-04-17
MF (application, 7th anniv.) - standard 07 1998-05-15 1998-05-13
MF (application, 8th anniv.) - standard 08 1999-05-17 1999-05-04
MF (application, 9th anniv.) - standard 09 2000-05-15 2000-06-01
Reinstatement 2000-06-01
MF (application, 10th anniv.) - standard 10 2001-05-15 2001-05-04
Final fee - standard 2001-08-30
2001-08-30
Reinstatement 2002-03-25
MF (application, 11th anniv.) - standard 11 2002-05-15 2002-05-07
MF (patent, 12th anniv.) - standard 2003-05-15 2003-05-01
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MATS MALMQUIST
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1994-06-03 2 71
Description 2001-08-29 8 325
Drawings 1994-06-03 1 18
Abstract 1994-06-03 1 57
Description 1994-06-03 7 302
Representative drawing 1999-01-19 1 3
Representative drawing 2002-08-13 1 5
Reminder - Request for Examination 1998-01-20 1 117
Acknowledgement of Request for Examination 1998-05-20 1 178
Courtesy - Abandonment Letter (Maintenance Fee) 2000-06-07 1 184
Notice of Reinstatement 2000-06-07 1 171
Commissioner's Notice - Application Found Allowable 2001-03-06 1 164
Courtesy - Abandonment Letter (NOA) 2001-11-18 1 171
Notice of Reinstatement 2002-04-04 1 174
Maintenance Fee Notice 2004-07-11 1 172
Fees 1998-05-12 1 42
Fees 2001-05-03 1 38
PCT 1992-11-12 8 235
Correspondence 2002-07-09 1 12
Correspondence 2001-08-29 2 63
Fees 2000-05-31 2 67
Fees 1999-05-03 1 40
Fees 1997-05-06 1 36
Fees 1996-05-14 1 36
Fees 1995-05-09 1 47
Fees 1994-05-03 1 34
Fees 1992-11-12 1 33